Completing the Circle: A History of Psychedelics and Harm Reduction
- 8 August 2024
- book chapter
- Published by Springer Nature
- p. 3-23
Abstract
Harm reduction officially entered the public health lexicon in the 1980s as a response to the HIV/AIDS crisis and its spread amongst intravenous drug users, but risk prevention has been an important part of psychedelic consumption in ways that predate this formal conceptualization. We look at psychedelic drug trials in the 1950s and 1960s to consider how people-first perspectives informed those early clinical studies, and how pioneering psychedelic researchers themselves approached risk management at a time that predates the formal recognition of harm reduction. Next, we follow psychedelic drugs out of the clinic and into music scenes and festivals that proliferated during the war on the drugs, where community-based organizations stepped up to support music fans who chose to combine psychoactive substances with dancing and drugs at all-day festivals. Finally, we reflect on the longer history and traditions of the Native American Church as one specific example of how Indigenous ceremonies involving psychedelic substances combined spirituality and healing in a community setting curated to promote wellness. Ultimately, we argue that psychedelic risk management has deep historical roots in psychedelic communities representing biomedical, cultural, and Indigenous perspectives – we might heed these historical lessons as we consider how to promote sustainable risk management strategies with psychedelics going forward.Keywords
This publication has 33 references indexed in Scilit:
- Connections are the Opposite of Addiction: Recovery Reading Groups in Public LibrariesPublic Library Quarterly, 2023
- Human Experimentation and Clinical Trials in Psychiatry2022
- Piaroa Shamanic Ethics and Ethos: Living by the Law and the Good Life of TranquillityInternational Journal of Latin American Religions, 2018
- Today’s fentanyl crisis: Prohibition’s Iron Law, revisitedInternational Journal of Drug Policy, 2017
- HIV, drugs and the legal environmentInternational Journal of Drug Policy, 2015
- Risk environments and drug harms: A social science for harm reduction approachInternational Journal of Drug Policy, 2009
- Merseyside, the first harm reduction conferences, and the early history of harm reductionInternational Journal of Drug Policy, 2007
- Harm reduction by a “user-run” organization: A case study of the Vancouver Area Network of Drug Users (VANDU)International Journal of Drug Policy, 2006
- The establishment of North America's first state sanctioned supervised injection facility: A case study in culture changeInternational Journal of Drug Policy, 2006
- LSD before Leary: Sidney Cohen's Critique of 1950s Psychedelic Drug ResearchIsis, 1997